Lam Research Corporation (LRCX)

AI-powered earnings prediction for Lam Research Corporation (LRCX).

244.92
+3.17%
USD, 2 days ago
Market Cap
306.37B
Google

Company Overview

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition products for dielectric film solutions; and VECTOR plasma-enhanced CVD products. It also provides Flex for dielectric etch applications; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. In addition, the company offers Coronus bevel clean products to enhance die yield; and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications. Further, it provides Reliant deposition, etch, and clean products; and Sense.i platform products, as well as customer service, spares, and upgrades. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.

Sector
Technology
Industry
Semiconductor Equipment & Materials
Phone
510 572 0200
Headquarters
4650 Cushing Parkway
Fremont, CA, 94538
United States
Full-Time Employees
19,700

Key Metrics

P/E Ratio (TTM)
50.09
Forward P/E
35.44
Price to Book
30.08
Beta
1.78
Profit Margin
30.22%
Gross Margin
49.80%
Return on Equity
65.56%
Return on Assets
21.05%
Earnings Growth
37.00%
Revenue Growth
22.10%
Dividend Yield
44.00%
Dividend Rate
$1.04

Financial Health

Total Cash
$6.18B
Total Debt
$4.48B
Debt to Equity
44.20
Current Ratio
2.26
Free Cash Flow
$4.82B
Operating Cash Flow
$7.12B

Analyst Recommendations

Target Price (Mean)
$274.42
Target High
$325.00
Target Low
$200.00
Recommendation
buy
Analyst Coverage
31 Analysts

Trading Ideas

Related Stocks